Современные подходы к ведению пациентов с острой печеночной недостаточностью

DOI: https://doi.org/10.29296/25877305-2020-02-16
Номер журнала: 
2
Год издания: 
2020

О. Бургасова, В. Тетова

Рассмотрены данные об этиопатогенезе и клинических проявлениях острой печеночной недостаточности (ОПН), а также современные подходы к ведению таких пациентов. Синдром ОПН, несмотря на успехи интенсивной терапии, представляет собой клинический синдром с высоким уровнем летальности, которая достигает 50%. Клиническая картина наиболее часто представлена развитием коагулопатии, энцефалопатии и полиорганной недостаточности. Тяжесть течения, вероятность необратимости ОПН, этиологическая неоднородность синдрома диктуют необходимость дальнейшей разработки терапевтических стратегий.
Ключевые слова: 
гепатология, печеночная недостаточность, печеночная энцефалопатия, этиопатогенез, вирусы, гепатотоксичность, лечение

Список литературы: 
  1. Bernal W., Wendon J. et al. Systematic review: Аcute liver failure // N. Engl. J. Med. – 2013; 369: 2525–34. DOI: 10.1056/NEJMra1208937
  2. Bower W., Johns M., Margolis H. et al. Population-based surveillance for acute liver failure // Am. J. Gastroenterol. – 2007; 102: 2459–63. DOI: 10.1111/j.1572-0241.2007.01388.x
  3. Kumar R., Shalimar, Bhatia V. et al. Antituberculosis therapy-induced acute liver failure: magnitude, profile, prognosis, and predictors of outcome // Hepatology. – 2010; 51: 1665–74. DOI: 10.1002/hep.23534
  4. Lee W., Stravitz R., Larson A. Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011 // Hepatology. – 2012; 55 (3): 965–7. DOI: 10.1002/hep.25551
  5. Wlodzimirow K., Eslami S., Abu-Hanna A. et al. Systematic review: acute liver failure – one disease, more than 40 definitions // Aliment. Pharmacol. Ther. – 2012; 35: 1245–56. DOI: 10.1111/j.1365-2036.2012.05097.x
  6. O’Grady J., Schalm S., Williams R. Acute liver failure: redefining the syndromes // Lancet. – 1993; 342: 273–75. Erratum, Lancet. – 1993; 342: 1000. DOI: 10.1016/0140-6736(93)91818-7
  7. Bernuau J., Rueff B., Benhamou J. Fulminant and subfulminant liver failure: definitions and causes // Semin. Liver Dis. – 1986; 6: 97–106. DOI: 10.1055/s-2008-1040593
  8. Mochida S., Nakayama N., Matsui A. et al. Re-evaluation of the Guideline published by the Acute Liver Failure Study Group of Japan in 1996 to determine the indications of liver transplantation in patients with fulminant hepatitis // Hepatol. Res. – 2008; 38: 970–9. DOI: 10.1111/j.1872-034X.2008.00368.x
  9. Hoofnagle J., Nelson K., Purcell R. Hepatitis // E. N. Engl. J. Med. – 2012; 367: 1237–44. DOI: 10.1056/NEJMra1204512
  10. Wasley A., Fiore A., Bell B. Hepatitis A in the era of vaccination // Epidemiol. Rev. – 2006; 28: 101–11. DOI: 10.1093/epirev/mxj012
  11. Кареткина Г.Н. Вирусный гепатит А в прошлом, настоящем и будущем // Инфекционные болезни: новости, мнения, обучение. – 2014; 3 (8): 38–48 [Karetkina G. Viral hepatitis A in the past, present and future // Infektsionnye bolezni: novosti, mneniya, obuchenie. – 2014; 3 (8): 38–48 (in Russ.)].
  12. Krasnitskiy E. Pathology and Hematology. Hepatocellular insufficiency. URL: http://pathanatom.ru/patologicheskaya-anatomiya/makroskopicheskaya-diagnostika/pechenochno-kletochnaya-nedostatochnost (in Russ.).
  13. Khuroo M., Kamili S. Aetiology and prognostic factors in acute liver failure in India // J. Viral. Hepat. – 2003; 10: 224–31. DOI: 10.1046/j.1365-2893.2003.00415.x
  14. Torres H., Davila M. Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer // Nat. Rev. Clin. Oncol. – 2012; 9: 156–66. DOI: 10.1038/nrclinonc.2012.1
  15. Larson A., Polson J., Fontana R. et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study // Hepatology. – 2005; 42 (6): 1364–72. DOI: 10.1002/hep.20948
  16. Сулима Д.Л. Печеночная недостаточность при хронических вирусных гепатитах: клиника, диагностика, прогноз и тактика лечения. Автореф. дис. ... д-ра мед. наук. СПб, 2008 [Sulima D.L. Pechenochnaya nedostatochnost’ pri khronicheskikh virusnykh gepatitakh: klinika, diagnostika, prognoz i taktika lecheniya. Avtoref. dis. ... d-ra med. nauk. SPb, 2008 (in Russ.)].
  17. Craig D., Bates C., Davidson J. et al. Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol-induced hepatotoxicity // Br. J. Clin. Pharmacol. – 2012; 73: 285–94. DOI: 10.1111/j.1365-2125.2011.04067.x
  18. Rezende G., Roque-Afonso A., Samuel D. et al. Viral and clinical factors associated with the fulminant course of hepatitis A infection // Hepatology. – 2003; 38: 613–8. DOI: 10.1053/jhep.2003.50366
  19. Paterson J., Mamdani M., Manno M. et al. Fluoroquinolone therapy and idiosyncratic acute liver injury: a population-based study // CMAJ. – 2012; 184 (14): 1565–70. DOI: 10.1503/cmaj.111823
  20. Jalan R., Olde Damink S., Deutz N. et al. Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension // Gastroenterology. – 2004; 127 (5): 1338–46. DOI: 10.1053/j.gastro.2004.08.005
  21. Lee W., Hynan L., Rossaro L. et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure // Gastroenterology. – 2009; 137: 856–64. DOI: 10.1053/j.gastro.2009.06.006
  22. Desjardins P., Du T., Jiang W. et al. Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure: role of glutamine redefined // Neurochem. Int. – 2012; 60: 690–6. DOI: 10.1016/j.neuint.2012.02.001
  23. Bernal W., Hall C., Karvellas C. et al. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure // Hepatology. – 2007; 46: 1844–52. DOI: 10.1002/hep.21838
  24. Vaquero J., Polson J., Chung C. et al. Infection and the progression of hepatic encephalopathy in acute liver failure // Gastroenterology. – 2003; 125: 755–64. DOI: 10.1016/s0016-5085(03)01051-5
  25. Etogo-Asse F.-E., Vincent R., Hughes S. et al. High density lipoprotein in patients with liver failure: relation to sepsis, adrenal function and outcome of illness // Liver Int. – 2012; 32: 128–36. DOI: 10.1111/j.1478-3231.2011.02657.x
  26. Butterworth R. Hepatic encephalopathy: a central neuroinflammatory disorder? // Hepatology. – 2011; 53: 1372–6. DOI: 10.1002/hep.24228
  27. Murphy N., Auzinger G., Bernal W. et al. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure // Hepatology. – 2004; 39: 464–70. DOI: 10.1002/hep.20056
  28. Jalan R., Olde Damink S., Deutz N. et al. Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension // Gastroenterology. – 2004; 127: 1338–46. DOI: 10.1053/j.gastro.2004.08.005
  29. Leithead J., Ferguson J., Bates C. et al. The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure // Gut. – 2009; 58: 443–4. DOI: 10.1136/gut.2008.154120
  30. O’Riordan A., Brummell Z., Sizer E. et al. Acute kidney injury in patients admitted to a liver intensive therapy unit with paracetamol-induced hepatotoxicity // Nephrol. Dial. Transplant. – 2011; 26: 3501–8. DOI: 10.1093/ndt/gfr050
  31. Davenport A. Continuous renal replacement therapies in patients with liver disease // Semin. Dial. – 2009; 22: 169–72. DOI: 10.1111/j.1525-139X.2008.00539.x
  32. O’Grady J., Alexander G., Hayllar K. et al. Early indicators of prognosis in fulminant hepatic failure // Gastroenterology. – 1989; 97 (2): 439–45. DOI: 10.1016/0016-5085(89)90081-4
  33. Tritto G., Davies N., Jalan R. Liver replacement therapy // Semin. Respir. Crit. Care Med. – 2012; 33: 70–9. DOI: 10.1055/s-0032-1301736
  34. Saliba F., Camus C., Durand F. et al. Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: a randomized, controlled trial // Ann. Intern. Med. – 2013; 159: 522–31. DOI: 10.7326/0003-4819-159-8-201310150-00005
  35. Demetriou A., Brown R. Jr., Busuttil R. et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure // Ann. Surg. – 2004; 239: 660–7. DOI: 10.1097/01.sla.0000124298.74199.e5
  36. Larsen F., Schmidt L., Wendon J. et al. Liver assisting with high-volume plasma exchange in patients with acute liver failure // Hepatology. – 2010; 52: 376A–376A.